Patent · US Active

Process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide

US10125164B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2015
Grant dateNov 13, 2018
Priority date
Expiry dateJul 25, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/0812
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to a process for solution-phase synthesis of D-Arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide, an active ingredient used for both common and rare diseases including a mitochondrial targeted therapy for ischemia reperfusion injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.